CAI vs XLP
Caris Life Sciences, Inc. Common Stock (CAI) versus XLP (XLP) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
XLP (XLP) common stock.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
XLP does not have a complete income-statement cache yet.
CAI currently screens at market cap $5.22B. XLP currently screens at market cap $0.
Not investment advice. Open the CAI and XLP stock pages for the full models.
Not investment advice.